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Development of two-photon polymerised scaffolds
for optical interrogation and neurite guidance of
human iPSC-derived cortical neuronal networks
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J. Madrid-Wolff, ef O. E. Olarte, eg S. Sokolovsky,h E. Estevez-Priego,ij
A.-A. Ludl,ijk J. Soriano, ij P. Loza-Alvarez,e B. N. Chichkov, lmn E. J. Hill, *a
H. R. Parri *a and E. U. Rafailov h
Recent progress in the field of human induced pluripotent stemcells (iPSCs) has led to the efficient production
of human neuronal cell models for in vitro study. This has the potential to enable the understanding of live
human cellular and network function which is otherwise not possible. However, a major challenge is the
generation of reproducible neural networks together with the ability to interrogate and record at the single cell
level. A promising aid is the use of biomaterial scaffolds that would enable the development and guidance of
neuronal networks in physiologically relevant architectures and dimensionality. The optimal scaffold material
would need to be precisely fabricated with submicron resolution, be optically transparent, and biocompatible.
Two-photon polymerisation (2PP) enables precise microfabrication of three-dimensional structures. In this
study, we report the identification of two biomaterials that support the growth and differentiation of human
iPSC-derived neural progenitors into functional neuronal networks. Furthermore, these materials can be
patterned to induce alignment of neuronal processes and enable the optical interrogation of individual cells.
2PP scaffolds with tailored topographies therefore provide an effective method of producing defined in vitro
human neural networks for application in influencing neurite guidance and complex network activity.
Introduction
Understanding the cellular and network mechanisms
underlying the functioning of the human brain is a major
goal of neuroscience. In addition to gaining insight into how
neurons interact to generate functions such as memory and
complex human attributes such as consciousness, such
understanding is also an essential step in enabling the
tackling of a range of neurological disease states. Conditions
such as schizophrenia, epilepsy, traumatic brain injury and
Alzheimer's disease continue to present major challenges to
sufferers and increasing socio-economic pressure
worldwide.1–3 The scientific and medical challenge is that
understanding human brain function at the cellular level is
constrained by limited access to diseased and non-diseased
living brain tissue.
Animal models have played a central role in elucidating
key mechanisms of neurodevelopment and
neurotransmission, but despite many attempts at
“humanising” models by implementing disease-causing
mutations from human studies, it is not always possible to
replicate complex neurological disorders in animals.4–7 To
determine relevant functional human mechanisms and their
disease related dysfunction it is therefore becoming clear that
patient-derived human cell models are required that allow
functional interrogation of cell–cell interactions from single
cells to the whole-network level.8–14
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The last decade has seen the emergence of neuronal
cultures derived from human induced pluripotent stem cells
(iPSCs) that has promise to be a technology that addresses
many of the major issues currently facing the field. Neuronal
cultures derived from iPSCs retain the disease genotype of
the original donor, and therefore present a highly relevant
model.
Developments with iPSC-derived neural cultures are
advancing rapidly, however a majority have so far focused on
deriving two dimensional planar cultures featuring a single
subtype of neural cells, and a limited number of functional
endpoints.15,16 In addition, a high variability of derived
neuronal cell types and a lack of defined network
architecture makes deriving conclusions from the analysis
potentially problematic.
Recent focus has moved to using organoids which exhibit
an in vivo-like morphogenic development program that
generates self-organising structures and a wide spectrum of
neural cells.17–19 Whilst organoids present an excellent
emerging model for neurodevelopmental studies, robust
cellular functional interrogation presents difficulties due to
variable organoid size and structure.20–22
A potential solution to achieving the goal of developing
controlled, low variability human neural networks with a
fully definable cell population is the use of biomaterial
scaffolds to guide and constrain cell interactions in three-
dimensions in a top-down modelling approach.14,23–28 The
field of tissue engineering has developed a multitude of
research directions including; printing of functionalised
proteins, microfluidics, polymer fibre extrusion, and polymer
hydrogels.29–32 For those interested in a comprehensive
review of this field that covers all these approaches please
refer to Zhuang et al.33 In particular there is a large medical
movement for reintroducing biological scaffolds as a
regenerative medicine for neuronal damage.34 However,
there is a key need for human in vitro structured neuronal
networks for basic functional research and pharmaceutical
testing. In recent years, micro-topographical surface relief
has shown promise in aligning neurite-like structures in
human and animal cell models.29,35–37 Production of aligned
electrospun nanofibers has similarly shown neurite
alignment and represents a promising model for
investigating spinal cord injury.30,38,39 Perhaps most
excitingly, technological advances in stereolithography, such
as two-photon polymerisation (2PP), have provided a precise
sub-micron-scale resolution for microfabrication of intricate
3D designs.40–42 Prior enlightening use of neuroblastoma
and carcinoma lines (e.g. NT2, SH-SY5Y, Neuro2a) has
shown the ability of these cell types for modelling neurite
extension in bespoke scaffolds.34 However, little is known
about the growth of human iPSC-derived neurons on 2PP
scaffold models, whether they are functionally viable over
physiologically relevant time periods and how scaffold
structure can influence network development in a
controllable manner to generate a defined underlying
functional architecture.
Alongside advances in tissue modelling, similar advances
have been made in the detection and monitoring of
functional network-based activity. Electrophysiology remains
the main methodology for single-cell and network functional
characterisation in human in vitro brain models, with multi-
well, high density and 3D multi-electrode arrays recently
becoming commercially available.43,44 However, single cell
resolution in networks where neurons may be in dense or
irregular arrangements is problematic. Current solutions to
these problems come from the emerging field of
optogenetics, particularly with the development of
genetically-encoded calcium and voltage indicators.45–47 In
combination with fast imaging systems such as light-sheet
fluorescence microscopy the use of genetically encoded
indicators enables whole-network 3D activity acquisition.48
However, to make full use of these technologies in vitro,
similar reproducibility and defined architecture of in vivo
neural networks is desirable.
In this study we aimed to identify suitable materials to
enable establishment of defined human neuronal networks
on two-photon polymerised scaffolds. Putative polymer
materialĲs) for 2PP should have three main properties once
polymerised: (1) optical properties compatible with bright
field and fluorescence functional imaging methodologies. (2)
Biocompatibility to sustain normal iPSC-derived neuronal
network development. (3) Printable via polymerisation at
micron scale resolution relevant for cell interaction and
guidance.
Here we report the identification and analyses of two
suitable biomaterials, polyethylene glycol diacrylate with
Irgacure 2959 (PEG2959) and Dental LT Clear (DClear), for
2PP to generate neural scaffolds using the criteria defined
above. Human neural precursors derived from iPSCs were
grown upon polymerised materials and differentiated to form
functional cortical neurons. We observed that neurons
cultured upon the surface of the materials matured
‘normally’ to form spontaneously active neuronal networks
that could be optically interrogated using fluorescent calcium
imaging and immunofluorescent staining. Furthermore, we
determined that micropatterning of 2PP materials could be
utilised to control the orientation of extending neurites,
influencing overall network development. Together, our
results demonstrate the utility of these materials and 2PP to
shape complex architectures in vitro, and pave the way
towards the development and monitoring of functional,
tailored neuronal microcircuits.
Methods
Generation of UV-polymerised pellets and two-photon
polymerised scaffolds
Four commercially available polymer materials were
considered as candidate materials: (i) SR-259, a polyethylene
glycol (200) diacrylate (PEG; Sartomer, Warrington, USA); (ii)
Dental LT Clear (DClear) a proprietary combination of
methyacrylic oligomers and glycol methacrylate (Formlabs,
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Berlin, Germany); (iii) polylactic acid (PLA); and (iv)
organically modified silicon (Ormosil).49 These materials
were used to produce planar pellets. To obtain a
photopolymerisable formulation, the photoinitiators Irgacure
369, Irgacure 651 or Irgacure 2959 (Ciba, Basel, Switzerland)
were added to the SR-259 at a concentration of 1% by
weight.50 For the PEG (200) and photoinitiator combinations,
these materials are referred to as PEG369, PEG651 and
PEG2959 in text and figures. As many commercially-available
photoinitiators are considered toxic, DClear was chosen due
to its established medical approval as a Class IIa
biocompatible resin (EN-ISO 10993-1:2009/AC:2010) indicating
that the proprietary photoinitiator supplied was also
identified as biocompatible. Planar polymer pellets with
diameters of 6 mm and a thickness of approximately 800 μm
were prepared from PEG369, PEG651, PEG2959, and DClear
material formulations by photopolymerisation with
ultraviolet (UV) light. For this purpose multi-well chambered
coverslips (Grace Bio-labs, Oregon, USA) were filled with
respective polymer and photoinitiator combinations, and
subsequently cured using UV light (254 nm, dose 24 J cm−2)
to form pellets. PLA and Ormosil photopolymers were
prepared using a concentration of 1% by weight of 4,4-
bisĲdiethylamino)benzophenone (Michler's ethyl ketone)
photoinitiator (Sigma Aldrich, Missouri, USA) and fabricated
via 2PP using a microscope objective (Zeiss Epiplan, 20×, NA:
0.4) at a laser wavelength of 780 nm (140 fs, 100 mW) as
previously described.51–53 Unexposed material was removed
by developing the PLA-4Bis samples in Ormodev (Micro resist
technology GmbH, Germany) and Ormosil-4Bis samples in
1-propanol. These test samples are referred as PLA-4Bis and
Ormosil-4Bis in text and figures.
Triangular surface topographies from DClear were
produced using 2PP in a further step on the prepared UV
cured DClear pellets as a surface substrate. A droplet of
DClear was applied to the pellet surface and covered with a
170 μm thick cover glass (#1.5 coverslip) using a 200 μm
spacer for creation of structuring volume. Triangular
structures (50 μm length × 20 μm width × 20 μm height, with
minimum 5 μm spacing in all directions) were then built on
the surface of the pellets by three-dimensional direct laser
writing using a commercial 2PP system (M4D, Laser
nanoFab, Hannover, Germany) on the basis of a CAD model.
A schematic illustration shows the experimental setup
applied for 2PP fabrication (Fig. 1). A microscope objective
(Zeiss Epiplan, 20×, NA: 0.4) was used for production, to
focus the femtosecond laser beam (780 nm, 140 fs, 100 mW)
into the photopolymer. The structuring was carried out at a
writing speed of 2 mm second−1 with 0.5 μm hatching and 5
μm slicing parameters. After removal of the coverslip the
structure was developed by 2-propanol to remove unexposed
material. Prior to usage all samples were sterilised for 24
hours in 70% volume/volume (v/v) ethanol, then washed
three times with sterile distilled water, followed by 7 days
curing in sterile distilled water.
Human iPSC-derived NPC plating and differentiation
Human iPSC-derived neural progenitor cells (ax0016, Axol
Bioscience Ltd., Cambridge, UK) were plated from frozen at 1
× 105 cells per cm2 onto SureBond (Axol Bioscience) coated
6-well plates using neural maintenance medium (Axol
Bioscience) and Y-27632 2HCl (10 μM, Selleck Chemicals,
Texas, USA) and cultured for 24 hours at 37 °C in a 5% CO2
environment.54 The plating medium was then replaced with
Neural Maintenance medium with recombinant human FGF2
(20 ng mL−1) for initial expansion. Once the necessary
number of cells was obtained, cells were terminally plated at
a density of 7.5 × 104 cells per cm2 on tissue culture plastic,
13 mm ϕ glass coverslips (Thermo Fisher Scientific,
Massachusetts, USA), as well as UV- and 2PP-fabricated
constructs in a 48-well plate (Corning, New York, USA). All
substrates were pre-coated with SureBond, a mouse laminin
solution, and Readyset, a polyethyleneimine solution (Axol
Bioscience) prior to seeding. Pre-coating with an extracellular
matrix substrate was used to support adhesion of human
NPCs and neurons, due to the typically bio-inert nature of
unmodified polymers and hydrogels.55 During initial plating
Fig. 1 Schematic illustration of the experimental setup applied for 2PP fabrication. A femtosecond laser beam (780 nm, 140 fs, 100 mW) was
focused onto a glass coverslip covering a photopolymer droplet using a microscope objective (Zeiss Epiplan, 20×, NA: 0.4). Using a XYZ stage, 2PP
samples were produced at a writing speed of 2 mm second−1.
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neural maintenance medium and Y-27632 2HCl (10 μM) was
used, which was replaced 24 hours later, with neural
maintenance medium without further supplementation and
then fully exchanged every 2–3 days. For the rapid
examination of neural projections on 2P-polymerised
substrates, after a further 24 hours in neural maintenance
medium alone, media was replaced with neural
differentiation-XF medium (Axol Biosciences) supplemented
with recombinant human BDNF (10 ng mL−1, Stem Cell
Technologies, Cambridge, UK) and recombinant human
GDNF (10 ng mL−1, Stem Cell Technologies) every 3 days.
Calcium imaging
Cultures were incubated in 10 μM Fluo-4 AM in DMSO
(Thermo Fisher Scientific) diluted in cell culture medium for
35 minutes at 37 °C in a 5% CO2 environment. Samples were
then washed with cell culture medium alone and incubated
for a further 10 minutes to recover. Samples were transferred
to a tissue perfusion chamber (RC-25, Warner instruments)
on the stage of a Nikon FN1 microscope (Nikon, Kingston-
upon-Thames, UK) and coverslip adhered in place using
silicon grease. The chamber was perfused with 37 °C pre-
warmed artificial cerebrospinal fluid (ACSF), a standard
buffer solution for electrophysiological recording, containing
the following: 126 mM NaCl, 5 mM KCl, 26 mM NaHCO3,
1.25 KH2PO4, 1 mM MgSO4, 2 mM CaCl2 and 10 mM
glucose.56 Calcium activity was acquired using an OptoLED
(Cairn Research, Faversham, UK) light source and FITC filter
cube (Chroma Technology, Vermont, USA) with Optomorph
image acquisition software (Cairn Research). Images were
acquired at 0.5 Hz with a 30 ms exposure time. Tetrodotoxin
citrate (TTX, 1 μM, Hellobio, Bristol, UK) and L-glutamate
(100 μM, Hellobio) were used to inhibit and excite calcium
transients respectively. Non-overlapping cells that displayed
spontaneous calcium transients and had a typical neuronal
morphology/soma size (<20 μm) were selected with an ROI
surrounding their soma and then followed throughout the
rest of the experiment.57
Live/dead cell viability staining
To determine viability, live cultures were incubated in
DMEM:F12 (Thermo Fisher Scientific) supplemented with 2
μM calcein-AM (green – live cells, Thermo Fisher Scientific)
and 4 μM ethidium homodimer-1 (red – dead cells, Thermo
Fisher Scientific) at 37 °C for 15 minutes before immediately
imaging using fluorescence microscopy to determine a live/
dead ratio. After washing with DMEM:F12 once to remove
excess dye, the cultures were imaged using 4× and 10×
objectives (Olympus, Tokyo, Japan) on a Olympus CKX53
microscope with a GXCAM Hichrome-MET camera (GT
Vision, Suffolk, UK), and pE-300 LED illumination source
(CoolLED, Andover, UK) for acquisition. Acquired images
were then processed and quantified using Image J – FIJI
(NIH, USA) to determine the percentage of live cells from the
total population.58,59 Viability was estimated from samples
harvested at 1 day in vitro (DIV), 7 DIV and 14 DIV post-
plating.
Immunocytochemistry
Cultures were fixed in 4% v/v formaldehyde (Sigma-Aldrich,
Missouri, USA) in 4% sucrose w/v (weight/volume) DPBS for 15
minutes at room temperature (RT), then rinsed thrice with
DPBS. Fixed cultures were incubated in permeabilisation buffer
(0.2% Triton X-100 (v/v, Sigma-Aldrich) in DPBS), for 10
minutes at RT, then transferred into blocking buffer (3%
Bovine serum albumin (w/v, Sigma-Aldrich) in permeabilisation
buffer) and incubated for 1 hour at RT. Primary antibodies were
prepared in blocking buffer and incubated with cultures
overnight at 4 °C. Primary antibodies used were: anti-
doublecortin (newborn neuron marker, 1 : 1000, Abcam), nestin
(intermediate progenitors marker, 1 : 200, Millipore), anti-beta
III tubulin (neuronal marker, 1 : 500, Abcam), anti-KI67 (mitotic
marker, 1 : 1000, Abcam), anti-paxillin 6 (telencephalic
progenitor marker, 1 : 300, Biolegend), anti-SOX2
(neuroepithelial progenitor marker, 1 : 300, R&D Systems), anti-
TBR1 (1 : 200, early-born cortical neuronal marker, Abcam),
anti-CTIP2 (1 : 200 early-born cortical neuronal marker, Abcam).
Samples were then rinsed thrice with DPBS and incubated in
secondary antibodies prepared in blocking buffer, protected
from light, for 1 hour at RT. Secondary antibodies used were
FITC Goat anti-Rabbit (Jackson ImmunoResearch,
Cambridgeshire, UK), Alexa Fluor 633 Goat anti-Mouse
(Abcam), and Alexa Fluor 543 Goat anti-Rat (Abcam). Cultures
were then rinsed thrice in DPBS, including DAPI (a nuclear
stain, 1 : 1000, Thermo Fisher Scientific) in the final rinse.
Samples were left protected from light, unmounted in DPBS
until imaging. Z-stacks of images were acquired using a TCS
SP5 laser scanning confocal microscope (Leica, Wetzlar,
Germany) with a 20× Leica water immersion objective. A
minimum of three randomly selected regions of interest were
imaged per replicate. To determine the number of bound cells
post-plating, the same protocol was followed with fixation and
permeabilisation, then was followed with a 30 minutes
incubation of ActinGreen 488 Readyprobes (Thermo Fisher
Scientific), followed with two DPBS rinses and incubation with
DAPI in DPBS. To quantify immunocytochemical staining of
cells positive for protein markers, a thresholded ROI mask was
generated from DAPI+ staining in FIJI, which was then used to
measure the mean pixel intensity in each ROI on its respective
protein marker image. Once a minimum threshold was set for
positive staining, the total number of ROIs that exceeded the
threshold was divided by the total number of ROIs to generate
a percentage of cells positive for the specific marker.58 To
quantify neurite filament intensity, a randomised mask with 10
square ROIs was overlaid on DAPI+ and filament images and
the mean pixel intensity measured. The mean pixel intensity of
each filament marker ROI was then divided by its respective
DAPI ROI to normalise the staining to quantity of cells. All
statistical analysis was performed using GraphPad Prism 8
(GraphPad, San Diego, USA).
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Quantitative and qualitative assessment of transmission
spectra, auto-fluorescence, and opacity of sample materials
To register the transmission spectra of candidate materials, a
LAMBA 950 spectrophotometer (Perkin Elmer, Massachusetts,
USA) was used. A calibration spectrum for air was acquired,
and followed by a control for a glass microscope slide. Small
flakes of candidate material were then adhered to a
microscope slide and later normalized to their spectra.
Spectra were recorded in the range 380–720 nm with steps of
5 nm.
The background auto-fluorescence of samples was
assessed using a TCS SP8 laser scanning confocal microscope
(Leica). A 405 nm diode laser was used to excite the polymers.
Illumination intensity was measured beforehand with a
S121C photodiode (Thorlabs, New Jersey, USA) to guarantee
comparability between different materials. Using the xyλ scan
mode, images were registered of the first surface of the
polymer at different wavelengths (λ), ranging from 425 to 705
nm, with a bandwidth of 10 nm. An emission spectra was
produced by averaging the intensity over a set area of the
polymer flake using FIJI. Continuous spectra were achieved
by interpolating the data.
Candidate materials were imaged under an inverted
fluorescence microscope to qualitatively assess their
transparency under typical imaging conditions. Excitation
and acquisition were achieved using a 60× Nikon (CFI APO
NIR, 1.0 NA, 2.8 mm WD) water immersion objective, and a
2× Nikon (CFI Plan Achro UW, 0.06 NA, 7.5 mm WD) air
objective, a mercury lamp, a FITC filter cube (Nikon), and a
QICAM Fast 1394 monochrome CCD digital camera
(QImaging, British Columbia, Canada). The transparency of
the scaffolds was evaluated by imaging 2 μm green
fluorescent beads (Estapor microspheres, Merck KGaA,
Darmstadt, Germany) through them. The beads were
attached to a coverslip coated with poly-L-lysine. Imaging was
performed by placing a single flake of each polymer within a
petri dish with a Corning cover-glass bottom, and, on top of
the polymer, the coverslip with the micrometric beads. The
dish was filled with distilled water and an exposure time of
50 ms was used to simulate imaging conditions. Contrast
and brightness were set equally for all images in FIJI.59
Assessment of neurite alignment
To calculate orientation of neuronal filaments, Z-stacks
acquired at 2 μm steps were first projected at maximum
intensity within each field of view, to ensure continuous
filament display. FIJI plugin “OrientationJ” was used to
quantitatively assess the distribution of orientations for
neurites (DCX+/TUJ1+) throughout the field of view.59,60
The orientation distribution measure A(θ) was normalised
to enable inter-sample comparisons. The peak distribution
angle A(θmax) was identified as the angle with the greatest
number of detected alignments. The mean value of the
orientation distribution is the integral of A(θ) over the range
of angles (Atotal) divided by the absolute value of angular
range (180°). The normalised distribution factor (NDF) is
obtained by dividing the peak value of the distribution
A(θmax) by the mean value of the orientation distribution, as
given by the formula below:
NDF ¼ A θmaxð Þ
A total=180°ð Þ
A higher NDF value indicates greater unidirectional
alignment of neurites. NDF values close to 1 indicate
isotropic growth of neurites.
Scanning electron microscopy (SEM) imaging of cultures on
scaffold material
To obtain high resolution images of the cultured cells on the
surface of the scaffold material, triangular patterned samples
were prepared for SEM imaging. Sample scaffold cultures
were initially fixed with 2.5% v/v Glutaraldehyde at RT for 1
hour, followed by several 5 minute washes. After fixation,
samples were dehydrated with graduated steps from graded
70% ethanol to 100% ethanol, followed by critical point
drying. The sample was mounted upon a metal stub and
sputter coated with platinum. Finally, the samples were
imaged using a JSM-6060 scanning electrode microscope (Jeol
USA, Massachusetts, USA) and Oxford Inca 300 EDS system
(Oxford Instruments, UK). Scanning electron microscopy was
conducted at the School of Metallurgy and Materials,
University of Birmingham.
Results
Material optical properties
While a number of studies have reported substrates for two
photon polymerisation, there is incomplete information on
biocompatibility and imaging capability of these polymer
scaffolds to examine network development and function.61
Optical transparency and low auto-fluorescence of the
polymerised scaffolds is a prerequisite to achieving
fluorescence-based protein visualisation and calcium activity
monitoring in 3D neural tissue constructs. Opaque or
dispersive polymers will impede imaging through the
material surface, a problem that will worsen once series of
layers are stacked upon each other, leading to incomplete
mapping of three-dimensional structures. Likewise, materials
with a high auto-fluorescence profile would reduce the signal
to noise ratio, limiting the ability to discern distinct calcium
indicator-visualised transients that are indicative of the
opening of voltage gated calcium channels during neuronal
transmission, and fluorescence-conjugated markers of
proteins. To determine the suitability for brightfield and
fluorescence imaging of the polymerised materials, UV-cured
pellets or two photon polymerised scaffolds were produced
using several candidate materials and photoinitiator
combinations, namely DClear, Ormosil-4Bis, PEG and PLA-
4Bis.
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Initially, a transmission spectrum was acquired to
determine the spectral absorption by the materials (Fig. 2A).
Whilst many of the PEG samples permitted transmission of
the majority of the 380–720 nm spectrum, which is relevant
to widely used biological commercially available fluorophores
(e.g. DAPI, FITC, GFP, TRITC, RFP, rhodamine Red-X, Texas
Red, Cy5), DClear demonstrated a transmission spectra
comparable to glass coverslips between 440–720 nm.
Ormosil-4Bis and PLA-4Bis, which were structured by 2PP,
exhibited reduced light transmission across the entire
spectrum with over 50% reduction in signal relative to
control. There was almost complete loss of transmission with
Ormosil-4Bis between 380–525 nm. Due to their low spectral
transmission Ormosil-4Bis and PLA-4Bis are poor candidate
materials for multi-layered scaffolds.
To determine the contribution of auto-fluorescence, 405
nm-excited signal intensity was measured over a wide visible
spectrum of 425–715 nm in 10 nm steps (Fig. 2B), then
normalised to produce a continuous spectrum (Fig. 2B, inset).
DClear exhibited the shortest auto-fluorescence wavelength
peak at 465 nm, a wavelength shorter than the emission peak
of key calcium indicators (Fluo4em 506 nm; GCaMP6em 512
nm; R-GECOem 590 nm; X-Rhod-1em 602 nm). PEG651 and
PEG2959 exhibited emission peaks between 500 to 525 nm
making them potentially unsuitable for imaging ultraviolet –
green spectrum fluorophores but not yellow – infrared
spectrum fluorophores. PEG369, PLA-4Bis and Ormosil-4Bis
exhibited emission peaks at 525–565 nm, making them
potentially unusable for distinguishing conventional green
spectrum fluorophores.
The main determinant of substrate utility is however
intensity of fluorescence. Ormosil-4Bis and PEG369 displayed
intensity which were orders of magnitude higher than the
lowest emitting samples PEG-2959 and DClear
Fig. 2 Optical characteristics of 2PP candidate materials. (A) Transmission spectra of candidate biomaterials over 380–720 nm in 5 nm steps.
Channelrhodopsin Chr2/H134 excitation wavelength (450 nm) and calcium indicators Fluo-4 AM (506 nm) and X-Rhod-1 AM (602 nm) emission
wavelengths are marked to represent widely used examples of optical interrogation tools for neuronal function. (B) Interpolated spectra of
fluorescence emission intensity from 405 nm laser-excited candidate materials, recorded from 425–705 nm, with a spectral bandwidth of 10 nm.
Inset, normalised graph highlighting emission peaks. (C) A normalised comparison between candidate materials to determine relative auto-
fluorescence emission using maximal values. (D) Images of candidate materials structured by UV (PEG2959, DClear) or two-photon polymerisation
(PLA, Ormosil) placed over green fluorescent beads and imaged using 405 nm-laser excitation. Scale bars = 50 μm. Arbitrary unit (AU).
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(Fig. 2C and D). Normalisation to DClear as lowest overall
fluorescence (1 arbitary unit, AU), produced relative intensity
magnitudes, with PEG2959 displaying lowest in the PEG-
photoinitiator combinations (1.3 AU), with Ormosil-4Bis
(1728.8 AU), PEG369 (779.9 AU) and PLA-4Bis (34.6 AU)
displaying the highest relative auto-fluorescence intensities
(Fig. 2C).
The most commonly used fluorescent calcium indicators
are green emitting (500–565 nm). To further determine the
utility of the candidate materials for imaging of such
fluorescence we therefore determined whether 2 μm green
fluorescent beads (470 nmex, 525 nmem) could be imaged
through the test materials. DClear and PEG2959 permitted
visualisation of the beads through the material (Fig. 2D).
However, Ormosil-4Bis and PLA-4Bis did not allow
visualisation of the beads through their structure.
Cell adhesion and viability
The spectral analysis revealed PEG2959 and DClear as the
most promising biomaterials and thus were selected for
continued study. Human iPSC-derived neural progenitors
were cultured upon these candidate materials, tissue-culture
treated plastic (TCPS), and glass coverslips to assess viability
of cell-biomaterial interactions (Fig. 3Ai). To demonstrate
suitability for adherent culture, density of adherent cells and
average cell spreading was measured 24 hours post-plating.
There was no significant difference (one-way ANOVA, F(3,16)
= 1.178, p = 0.349) between the density of adhered cells
determined by total nuclei visualised by DAPI+ staining in
each of the four conditions; TCPS, Glass, DClear and PEG
(Fig. 3Aiii and B). To determine whether nuclei density
represented a good measure of adherence, cell spreading was
also determined by calculating the average surface area per
cell via the phallodin-labelled F-actin distribution per nuclei
(Fig. 3Aii and C). F-Actin is an essential component of
eurkaryotic cytoskeletons, and thus is largely distributed
throughout the cell. Again no significant difference was seen
between all conditions (one-way ANOVA, FĲ3,16) = 2.343, p =
0.112).
When using non-biological materials in cell culture it is
important to determine any acute or chronic toxicity the
material may present. However, as NPCs are a self-renewing
population, the proportion of total viable cells should
increase, rather than decrease over time. To determine the
viability of adherent cultures grown directly on the candidate
materials cell viability was assessed at 24 hours, 15- and 30-
days post-plating (Fig. 3D). The percentage of living cells
(green; calcein AM) was normalised against the total number
of cells including dead (red; ethidium homodimer-1) for each
sample. Whilst, there was a significant increase in cell
viability over time on TCPS and DClear (paired T-test, TCPS
T(3) = 16.79, p < 0.001; DClear T(3) = 3.454, p = 0.0408),
PEG2959 and glass displayed no significant change in
viability. At no time point was there significant difference
(one-way ANOVA) in viability of cells grown on any of the
materials tested compared to the control TCPS (Fig. 3D),
suggesting that viability was not significantly impaired in any
condition, despite lack of significant changes in viability for
PEG2959 and glass.
Differentiation of hNPCs
A key consideration in the use of novel biomaterials are
potential effects on differentiation capacity. To estimate
differentiation efficiency, the proportion of cells staining for
specific cell markers of neural progenitors, KI67+ (mitotically
active), nestin+ (intermediate filaments), and those for TUJ1+
early post-mitotic neurons, were compared over time and
between conditions. Additionally PAX6+ and SOX2+
expression was used to show cortical progenitor identity.
Initially, at 2 DIV post-plating, a high proportion of cells
positively express KI67 (Glass, 72.06 ± 1.97%; DClear, 77.65 ±
2.65%; PEG2959, 69.51 ± 3.04%) with a high intensity of
nestin (Glass, 0.639 ± 0.052 AU; DClear, 1.082 ± 0.130 AU;
PEG2959, 0.777 ± 0.074 AU, relative intensity) relative to TUJ1
staining (Glass, 0.111 ± 0.026 AU; DClear, 0.120 ± 0.028 AU;
PEG2959, 0.165 ± 0.034 AU, relative intensity) indicating a
largely progenitor population (Fig. 4A–C). At 30 DIV post-
plating a significant increase in the relative proportion of
TUJ1+ neurons was identified (paired T-test, Glass, T(7) =
4.292, p < 0.01; DClear, T(7) = 5.794, p < 0.001; PEG2959,
T(7) = 4.064, p < 0.01). Conversely, a significant decrease in
overall KI67+ (paired T-test, Glass, T(8) = 18.94, p < 0.0001;
DClear, T(8) = 20.72, p < 0.0001; PEG2959, T(8) = 12.28, p <
0.0001) and an increase in nestin+ intensity was also seen
(paired T-test, Glass, T(8) = 3.196, p = 0.0127; Dclear, T(10) =
3.337, p < 0.01; PEG2959, T(8) = 3.920, p < 0.01). However it
was a smaller fold increase compared with the increase in
TUJ1+ intensity (Glass, 5.46× Nes, 31.36× TUJ1; DClear, 2.77×
Nes, 16.32× TUJ1; PEG2959, 2.74× nestin, 9.71× TUJ1).
Neither PEG2959 nor DClear appeared to significantly inhibit
KI67+ progenitor maturation to post-mitotic (KI67−) neurons
or post-mitotic neuronal survival over a 30 day period as
previously shown by viability data (Fig. 4D).
When determining neuronal health it is crucial to
consider both the viability of the cells and also their ability to
form physiologically functional networks. To determine
activity, 50 DIV cultures on PEG2959 and DClear were loaded
with cell permeable Fluo-4 AM, a dye which shows
fluorescence increase upon calcium ion influx into the cell,
typically via voltage-gated calcium channels when depolarised
by neuronal firing. These cultures displayed spontaneous
calcium transients, which were significantly blocked (paired
T test, DClear, T(39) = 12.25, p < 0.001); PEG2959, T(39) =
7.486, p < 0.001) by the presence of voltage-gated sodium
channel blocker TTX (1 μM) in >90% of active cells (Fig. 4E).
As voltage-gated sodium channels are required for action
potential generation, this indicates a dependence on action
potentials for the observed calcium transients. No significant
difference in the amount of spontaneous activity was noted
between DClear and PEG2959, meaning similar activity levels
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Fig. 3 Candidate material biocompatibility for long-term adherent cultures. (A) i) Representative images of Phalloidin (green) and DAPI (blue)
staining 24 hours post-plating on polystyrene and DClear with human neural progenitor cells. Scale bars = 500 μm. ii) F-Actin expression with
thresholded image below. iii) Nuclei localisation with thesholded image below. (B) 24 hours post-plating adherent nuclei were quantified by
number of thresholded DAPI+ regions of interest. (C) Mean surface area per cell (μm2) quantified by normalising total area of F-actin expression
(Phallodin+ ROIs) against total number of nuclei (DAPI+ ROIs). (D) Representative images of live (calcein-AM+, green) and dead (Ethd1+, red) viability
staining at 1 DIV (days in vitro) and 30 DIV post-plating of human neural progenitor cells. Scale bars = 100 μm. (E) % viability (calcein-AM+) of cells
was quantified against total cell population. *p < 0.05, ***p < 0.001. Data represented as mean + s.e.m.
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Fig. 4 Assessment of neural progenitor efficiency in differentiation into functionally active post-mitotic neurons. (A) Representative images of
fluorescence immunocytochemistry for protein markers. Mitotically active neural progenitors which are (i) SOX2+ (magenta) and PAX6+ (green), (ii)
nestin+ (magenta) and KI67+ (green), naturally differentiated into post-mitotic neurons which are (iii) TUJ1+ (yellow) and KI67−/nestin−, from (A) 2
DIV (days in vitro) post-plating to (B) 30 DIV post-plating. Cells were grown on each DClear and PEG2959 for comparison against glass coverslips.
DAPI+ (blue) staining indicates nuclear material. Scale bars = 100 μm. (C) Quantification of percentage positive staining for PAX6/SOX2 at 2 DIV,
and KI76 at 2 DIV and 30 DIV. N ≥ 8 (D) relative intensity of nestin+ and TUJ1+ staining at 2 DIV and 30 DIV. N ≥ 8 (E) DIV 50 post-plating neural
cultures on candidate materials DClear and PEG2959 cells displayed action potential dependent calcium transients that were blocked with TTX (1
μM) addition. N = 40 cells. *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001. Data represented as mean + s.e.m. (F) Representative field of view
with ROIs indicated for calcium imaging traces of 50 DIV post-plating cells loaded with Fluo-4 AM. Traces show spontaneous calcium elevations,
which are blocked by TTX (1 μM) addition. Cells displayed elicited calcium transients to excitatory neurotransmitter glutamate (100 μM) addition.
Yellow bars signify where ≥4 cells show synchronised firing. Scale bar = 50 μm.
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Fig. 5 Alignment of neuronal filaments by two-photon micro-guidance patterning. (A) Representative scanning electron microscopy images of
unidirectional and bidirectional two-photon polymerised micro-guidance triangles. Scale bars = 40, 50 and 100 μm. (B) Representative images of
14 DIV (days in vitro) post-mitotic neurons grown on patterned and planar platforms. Neurites are represented by TUJ1+ (green) and DCX+
(magenta) staining. DAPI represents nuclear material (blue). Dotted white line displays localisation of triangular patterning. Magnified regions
display alignment of TUJ1+ neurites. Scale bars = 100 and 50 μm. (C) Representative distributions of orientation quantified from immunostained
neurites. (D) Comparison of normalised distribution factor indicates significantly higher likelihood of alignment on triangular patterned pellets
compared with planar pellets, or planar areas on patterned pellets. Planar pellets N = 18, bidirectional triangular pellets N = 6, unidirectional
triangular pellets N = 12, planar areas on patterned pellets N = 6. ****p < 0.0001. (E) SEM images with false-coloured (magenta) neuronal cell
bodies and neurites of (i) cells on DClear triangular micro-structure, (ii) aligned neurites exiting the edge of the patterned area, (iii) an unpatterned
area of D-Clear. Scale bars = 20 μm.
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were present in cultures on different candidate materials.
Synchronised calcium elevations in different imaged neurons
confirmed network-level activity (Fig. 4F, yellow bars).57 The
presence of functional glutamate receptors, the main
neurotransmitter of the cortex, was established with 100% of
cells displaying elicited calcium transients upon acute
glutamate (100 μM) addition (Fig. 4F, N = 40).
Guidance of neuronal processes by 2PP generated
microstructures
Morphogen gradients and precise spatial patterning enable
the development of defined networks of neurons in vivo.
However, controlling the development of networks in vitro is
a significant challenge. Small scale studies using
microfluidics, micropatterning and aligned fibres have
demonstrated great promise.30,62 However, 2PP provides
much greater resolution than can be achieved by using other
methods. To determine whether directionally-oriented
neuronal networks can be prepared with structural
modifications, 2PP was used to print micron-scale triangular
guidance motifs with DClear polymer (Fig. 5A). Previous
studies in microfluidics and micropatterning have shown
that constrictive funnel motifs may be employed to gate
directional neurite extension.29,63–65 Building upon these
findings, we used 2PP to fabricate a matrix of 2.5D triangles
in a repeated pattern, with the aim of guiding directional
neurite extension over relatively large distances (>500 μm).
Progenitors cultured upon patterned and planar unpatterned
platforms were synchronously differentiated and analysed to
determine their distribution and orientation (Fig. 5B).
Triangular micro-patterning demonstrated a highly clustered
orientation distribution with a single central peak, whereas
on the planar areas of patterned platforms (defined as a
planar region >1000 μm distant from the surface
modifications), or unpatterned platforms distribution
appeared random (Fig. 5C).
To evaluate whether the degree to which neurites align on
the triangular patterned surfaces was significant, a series of
comparisons were made between three conditions, namely
planar pellets (n = 18), triangular-patterned pellets (n = 18),
and planar areas on patterned pellets (n = 6). For each
condition, additional analyses were carried out on
fluorescence localisation of (i) DCX+, a marker for migrating
newborn post-mitotic neurons, and (ii) TUJ1+, a marker for
maturing post-mitotic neurons, to determine if the effect is
prevalent in migrating and maturing neurons. A significant
difference was observed between alignment in planar pellets
and triangular-patterned pellets in DCX (unpaired T-test,
T(34) = 17.40, p < 0.0001) and TUJ1 images (unpaired T-test,
T(34) = 12.67, p < 0.0001). As an internal control, triangular-
patterned pellets tested against planar areas on patterned
pellets displayed significant difference between both DCX
(paired T-test, T(5) = 18.62, p < 0.0001) and TUJ1 images
(paired T-test, T(5) = 5.683, P < 0.01). However, no significant
difference was observed between planar pellets and planar
areas on patterned pellets. Further tests performed between
DCX and TUJ1 images in the same condition to determine
whether neuronal maturity influenced orientation also
reported no significant difference between DCX+ migrating
newborn and TUJ1+ maturing neurons. Finally, no significant
difference in neuronal alignment between unidirectional (n =
12) and bidirectional triangular (n = 6) motifs was observed.
Using scanning electron microscopy, we can see that neurites
extend along the surface of DClear, and often grown along
the side of the triangular micro-pattern (Fig. 5E).
Discussion and conclusions
Human iPSC-derived in vitro CNS models have great potential
in enabling the determination of mechanisms of human
neuronal function and dysfunction in disease.13,15,21,66,67
However, due to the low complexity of monocultures and
variability of patient-derived human cell models in forming
neuronal networks, the process of developing novel
therapeutics is currently hampered. Organoids, which exhibit
more complex structure and cellular interactions have
applications for investigating neurodevelopment, however,
reported high variability in sample-sample and batch-batch
preparations of CNS organoids make them currently less than
optimal candidates for robust functional interrogation and
standardised therapeutic screening.20,68,69 Micropatterning,
2.5 and 3D scaffolds therefore has great potential in
providing a low variability structure on the basis of which
defined networks can develop, resulting in predictable
networks and a clearer understanding via functional
interrogation.33
In this study, we identify two suitable materials for the
fabrication of micropatterned surfaces using 2PP to guide
human neuronal network development. Dental LT Clear
(DClear), and a combination of PEG-DA and Irgacure 2959
were found to meet the required criteria of optical
transparency with a low auto-fluorescence profile,
amenability to 2PP at the micron scale and biocompatibility
with cultured human neurons. These materials were not
neurotoxic and permitted long-term adherence and normal
differentiation of iPSC-derived neuronal progenitors to
mature, functional neurons. PEG has previously been used
with cultures of iPSC-derived neurons, however it is usually
crosslinked with other molecules (e.g. hyaluronic acid) or as a
high intensity phase emulsion (HIPE), and also employed as
a hydrogel.31,70–72 PEG2959 has also been reported as suitable
for two-photon polymerisation and culture with mouse
fibroblasts, endothelial cells and bovine aortic cells, however
to our knowledge this study is the first to report its
suitability, alongside DClear, for usage as a 2PP substrate for
human iPSC-derived neuronal cultures.61,73,74 Accardo et al.
reported the development of 3D scaffolds for neuronal
cultures from high molecular weight PEGDA (Mw = 700 DA)
using Irgacure 819 as photoinitiator. In this study, scaffolds
also featured very low auto fluorescence emission and were
able to support detailed two-photon microscopy for
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immunofluorescence analysis of neuroblastoma cells
cultured on these scaffolds.42 However, as reported in this
and other work, PEGDA formulations are well known to
exhibit a water-induced swelling ratio in the range of 11–
60%.50,75,76 Such swelling properties of substrates are
incompatible with the aim to fabricate micro-patterns with
resilient and reproducible geometries when applied to the
goal of precise neurite guidance. Material swelling may result
in poor adhesion of micro-structures to the substrate,
undesired micro-structure deformation, disruption of protein
coatings, and even detachment of cell layers during
prolonged culture. In our study, it was our intention to use
biocompatible polymers with low or non-swelling behaviour
(low molecular weight) to later fabricate surface structures of
robust, highly reproducible geometry for studying the
development of iPSC-derived neuronal networks in vitro. The
geometry of 2PP fabricated triangular surface structures from
DClear is characterized by a high conformity with the original
CAD design (Fig. 5A). This surface patterning could be
reproducibly fabricated and applied to the systematic
evaluation of patterning effect on alignment of neuronal
filaments.
Several previously reported materials used for two-photon
polymerisation (e.g. PLA-4Bis, Ormosil-4Bis, PEG369) did not
meet the required criteria, including transmission of
standard fluorophore emission wavelengths (∼400 nm – 650
nm) and low auto-fluorescence. DClear displayed the lowest
relative auto-fluorescence of the polymerised candidate
materials tested, and a compatible spectrum of auto-
fluorescence for imaging with fluorescent calcium indicators
or protein-bound fluorophores. Furthermore, together with
PEG2959 it exhibited near total transmission of light across
the visible spectrum, making a suitable candidate for
building multi-layered scaffolds for optical interrogation.
Previous studies have similarly demonstrated the growth of
iPSC-derived cells within 2PP fabricated scaffolds, with a
notable mention being the development of a scaffold to graft
iPSC-derived retinal cells in a physiologically relevant
manner.77 However, these two-photon polymerised materials
were auto-fluorescent, only allowing observation of the
outward face of the scaffold.78–81 The use of DClear and
PEG2959 enabled fluorescence calcium imaging at single
neuron resolution revealing complex cellular and
synchronised network activity. This promises the dual
benefits of optical functional interrogation and investigation
of protein expression, achievable at a high-throughput level,
as well as the expansion of the materials usage towards
developing bespoke 3D scaffolds.
The ability to influence neuronal network structural
architecture and directionality of neurite outgrowth and
cellular positioning is of great scientific and functional
interest.34,62,82,83 Control of connectivity between separate
populations of neurons is necessary to generate defined
neuronal networks, with previous studies reporting neurite-
selective or directional innervation using microfluidic
devices.14,64,84 Other solutions include micro-contact printing
of peptides, proteins and photopolymer resists, nanospun
fibres, aligned polymer gels and many more, however
resulting interactions are often low complexity, e.g. a single
divider between population A and population B, low control,
or the method of fabrication would not suit expansion to 3D
paradigms.32,38,70,85–95 The benefit of 2PP fabricated
structures is that they can be as complex or simple as the
experiment necessitates with a micron-scale resolution for
printing. Whilst large scale 2PP arrays take considerable time
to prepare, a combination approach with UV-polymerised
macro structures, as demonstrated in this study, may soon
overcome the scalability issue of transitioning from micron
to millimetre printing resolution.
Using 2PP micropatterned matrices of low angle of
incidence triangles resulted in unidirectional alignment of
neurites for up to 500 μm. Triangular surface modifications
were chosen based on the hypothesis that during neurite
guidance of in vitro neurons, growth cones tend to grow
straight, and large turn angles can often be a marker for
growth cone collapse or reversal.96,97 Thus the ideal situation
was to offer shallow angles in a repeated pattern to
encourage straight neurite extension, without forcing the
neurites into separate tracts entirely (e.g. by use of a
microgroove) as neuronal tracts in the cortex often have
overlapping segments. Interestingly, there was no significant
difference in neuronal alignment between unidirectional and
bidirectional triangular motifs, an unexpected finding as the
bidirectional triangular motifs offer frequent potential
obstruction, and a lack of “funnelling” structure of gradually
tightening restriction when compared with the unidirectional
structures. This suggests that alignment was not dependent
upon funnelling of neurons, as in a previous study but rather
a regularly situated low-angle of incidence obstruction that
guides neurite extension.63 Employing similar, yet more
complex 2PP matrices to influence neurite extension over
long distances may be a useful approach for developing
optimal topography for programmed synaptic formation,
resulting in reproducible neural networks with definable
functional architectures.
In conclusion, DClear and PEG2959 represent suitable
polymers for two-photon polymerisation of patterning at the
micron scale, allowing the establishment of neuronal
networks, and optical interrogation for functional and
morphological studies. To our knowledge, this study is the
first to report the growth of iPSC-derived cortical neurons on
2PP micropatterned surfaces, as well as the first to optically
observe functionality of human iPSC-derived neurons upon
suitable materials for two-photon polymerisation.
Additionally, DClear has not previously been used to produce
2PP generated micropatterned surfaces or scaffolds for cell
culture. Its properties met all our set criteria for a
biocompatible 2PP scaffold material and its status Class IIa
biocompatible resin with approval for prolonged contact with
human tissues makes long term pharmacological/tissue
engineering studies feasible. The compatible combination of
iPSC-derived neural cultures with optically-interrogatable
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materials that can be intricately patterned to influence
network architecture represents a promising advance in the
development of 3D scaffolds for structurally-defined and
reproducible network development.
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